12:00 AM
 | 
Jul 13, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Paloxi palonosetron regulatory update

Helsinn said the Multinational Association for Supportive Care in Cancer and the European Society of Medical Oncology updated their antiemesis guidelines to recommend palonosetron as the...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >